Free Trial

Smart for Life (SMFL) Competitors

Smart for Life logo
$0.0060 +0.00 (+445.45%)
As of 10/3/2025 02:52 PM Eastern

SMFL vs. VINC, NCNA, PBLA, HSTO, VRPX, TRVN, SCPS, ARDS, NAVB, and EVLO

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Vincerx Pharma (VINC), NuCana (NCNA), Panbela Therapeutics (PBLA), Histogen (HSTO), Virpax Pharmaceuticals (VRPX), Trevena (TRVN), Scopus BioPharma (SCPS), Aridis Pharmaceuticals (ARDS), Navidea Biopharmaceuticals (NAVB), and Evelo Biosciences (EVLO). These companies are all part of the "pharmaceutical products" industry.

Smart for Life vs. Its Competitors

Vincerx Pharma (NASDAQ:VINC) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

Smart for Life's return on equity of 0.00% beat Vincerx Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Vincerx PharmaN/A -248.33% -132.73%
Smart for Life N/A N/A N/A

Vincerx Pharma has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500. Comparatively, Smart for Life has a beta of 16.69, meaning that its stock price is 1,569% more volatile than the S&P 500.

Vincerx Pharma presently has a consensus target price of $40.00, suggesting a potential upside of 78,485.46%. Given Vincerx Pharma's stronger consensus rating and higher possible upside, equities research analysts clearly believe Vincerx Pharma is more favorable than Smart for Life.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vincerx Pharma
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Smart for Life
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Smart for Life has higher revenue and earnings than Vincerx Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vincerx PharmaN/AN/A-$40.16M-$20.600.00
Smart for Life$11.11M0.00-$22.68MN/AN/A

In the previous week, Vincerx Pharma had 1 more articles in the media than Smart for Life. MarketBeat recorded 1 mentions for Vincerx Pharma and 0 mentions for Smart for Life. Smart for Life's average media sentiment score of 0.00 beat Vincerx Pharma's score of -1.00 indicating that Smart for Life is being referred to more favorably in the news media.

Company Overall Sentiment
Vincerx Pharma Negative
Smart for Life Neutral

44.0% of Vincerx Pharma shares are owned by institutional investors. Comparatively, 28.4% of Smart for Life shares are owned by institutional investors. 15.6% of Vincerx Pharma shares are owned by company insiders. Comparatively, 31.7% of Smart for Life shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Smart for Life beats Vincerx Pharma on 7 of the 12 factors compared between the two stocks.

Get Smart for Life News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$43K$3.56B$6.08B$10.54B
Dividend YieldN/AN/A5.68%4.70%
P/E RatioN/A9.7678.0526.71
Price / Sales0.0086.06579.79179.45
Price / CashN/A5.6237.7961.25
Price / Book0.001.2312.556.56
Net Income-$22.68M$17.44M$3.31B$277.70M
7 Day PerformanceN/A8.64%4.28%2.41%
1 Month PerformanceN/A18.90%7.85%9.30%
1 Year PerformanceN/A-5.74%71.37%31.22%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMFL
Smart for Life
N/A$0.01
+445.5%
N/A-85.0%$43K$11.11M0.00110Gap Down
VINC
Vincerx Pharma
2.5696 of 5 stars
$0.05
+23.2%
$40.00
+73,700.7%
-99.6%$284KN/A0.0060Short Interest ↑
Gap Up
NCNA
NuCana
0.6017 of 5 stars
$4.86
+4.7%
N/A-98.8%$146KN/A-0.0130Positive News
PBLA
Panbela Therapeutics
0.1179 of 5 stars
$0.01
-77.8%
N/A-96.9%$54KN/A0.006
HSTO
Histogen
N/A$0.01
+4,900.0%
N/A-99.9%$43K$19K0.0020Gap Up
VRPX
Virpax Pharmaceuticals
0.0585 of 5 stars
$0.02
-40.2%
N/A-99.9%$26KN/A0.007Gap Down
TRVN
Trevena
2.0436 of 5 stars
$0.02
+25.0%
$5.00
+33,233.3%
-99.7%$14K$443K0.0040Gap Up
SCPS
Scopus BioPharma
N/A$0.00
flat
N/A+0.0%$13KN/A0.009
ARDS
Aridis Pharmaceuticals
N/A$0.00
-84.6%
N/AN/A$11KN/A0.0030Gap Down
NAVB
Navidea Biopharmaceuticals
N/A$0.00
flat
N/A-90.0%$10K$8.13K0.0010High Trading Volume
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120News Coverage
Options Volume

Related Companies and Tools


This page (NASDAQ:SMFL) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners